Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NON-INVASIVE PRENATAL TESTING (NIPT) OF FETAL SINGLE-GENE DISORDERS IN MATERNAL BLOOD

NCT02339402 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02339402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02339402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NON-INVASIVE PRENATAL TESTING (NIPT) OF FETAL SINGLE-GENE DISORDERS IN MATERNAL BLOOD
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2014
Completion date
May 31, 2018
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary disease